Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Go Yamamoto

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Antimicrobial Agents and Chemotherapy|March 14, 2018
Micafungin Breakthrough Fungemia in Patients with Hematological DisordersMuneyoshi Kimura, Hideki Araoka, Hisashi Yamamoto, et al.
International Journal of Hematology|November 25, 2024
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit studyTsuyoshi Muta, Yosuke Masamoto, Go Yamamoto, et al.
British Journal of Haematology|September 24, 2021
Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseasesDaisuke Kaji, Manabu Kusakabe, Mamiko Sakata-Yanagimoto, et al.
Haematologica|October 15, 2020
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II studyKana Miyazaki, Naoko Asano, Tomomi Yamada, et al.
International Journal of Hematology|December 1, 2016
Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in JapanMichinori Ogura, Kenichi Ishizawa, Dai Maruyama, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 28, 2023
Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphomaEiju Negoro, Takahiro Yamauchi, Noriko Fukuhara, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2021
Clinical and Microbiological Characteristics of Proven Invasive Aspergillosis Due to Rare/Cryptic Species in Allogeneic Hematopoietic Stem Cell Transplant RecipientsRyosuke Yamamuro, Muneyoshi Kimura, Yuki Asano-Mori, et al.
Mycopathologia|February 5, 2026
Fatal Ultra-Early-Onset Rhino-Cerebral Mucormycosis Caused by Rhizomucor miehei Following Umbilical Cord Blood Transplantation and Review of Published LiteratureKumi Nitta, Shinsuke Takagi, Otoya Watanabe, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2022
Factors Associated with Breakthrough Fungemia Caused by <i>Candida</i>, <i>Trichosporon</i>, or Fusarium Species in Patients with Hematological DisordersMuneyoshi Kimura, Yuki Asano-Mori, Takashi Sakoh, et al.
Cancer Science|February 12, 2021
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyNobuhiko Yamauchi, Dai Maruyama, Ilseung Choi, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|March 14, 2018
Micafungin Breakthrough Fungemia in Patients with Hematological DisordersMuneyoshi Kimura, Hideki Araoka, Hisashi Yamamoto, et al.
International Journal of Hematology|November 25, 2024
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit studyTsuyoshi Muta, Yosuke Masamoto, Go Yamamoto, et al.
British Journal of Haematology|September 24, 2021
Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseasesDaisuke Kaji, Manabu Kusakabe, Mamiko Sakata-Yanagimoto, et al.
Haematologica|October 15, 2020
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II studyKana Miyazaki, Naoko Asano, Tomomi Yamada, et al.
International Journal of Hematology|December 1, 2016
Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in JapanMichinori Ogura, Kenichi Ishizawa, Dai Maruyama, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 28, 2023
Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphomaEiju Negoro, Takahiro Yamauchi, Noriko Fukuhara, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2021
Clinical and Microbiological Characteristics of Proven Invasive Aspergillosis Due to Rare/Cryptic Species in Allogeneic Hematopoietic Stem Cell Transplant RecipientsRyosuke Yamamuro, Muneyoshi Kimura, Yuki Asano-Mori, et al.
Mycopathologia|February 5, 2026
Fatal Ultra-Early-Onset Rhino-Cerebral Mucormycosis Caused by Rhizomucor miehei Following Umbilical Cord Blood Transplantation and Review of Published LiteratureKumi Nitta, Shinsuke Takagi, Otoya Watanabe, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2022
Factors Associated with Breakthrough Fungemia Caused by <i>Candida</i>, <i>Trichosporon</i>, or Fusarium Species in Patients with Hematological DisordersMuneyoshi Kimura, Yuki Asano-Mori, Takashi Sakoh, et al.
Cancer Science|February 12, 2021
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyNobuhiko Yamauchi, Dai Maruyama, Ilseung Choi, et al.
Pageof 15